[Skip to Navigation]
Views 2,760
Citations 0
Clinical Trials Update
August 28, 2018

Automated Device Improves Glucose Control in Hospitalized Patients

JAMA. 2018;320(8):749. doi:10.1001/jama.2018.12042

Recent research has shown that a closed-loop insulin delivery system—also known as an artificial pancreas—controls glucose more effectively than standard subcutaneous insulin therapy during hospitalization.

The investigators randomly assigned 136 adults with type 2 diabetes who needed insulin to receive it with the automated system or via standard subcutaneous therapy for 15 days or until they were discharged.